The KG also prioritized anti-epiletic therapies that target SCN5A-regulated ion channels in the conduction system as treatments for AF, and vorinostat as a repurposed treatment for MI that targets HDAC6 regulation of mitochondrial biogenesis41. Here, SCN5A is linked to atrial fibrillation.